ParkinsonFranceV1, PubMed, Curation, bibRecord, 000993

[Disease-modifying therapies in PD].

Identifieur interne : 000993 ( PubMed/Curation ); précédent : 000992; suivant : 000994

[Disease-modifying therapies in PD].

Auteurs : Olivier Rascol [France]

Source :

Rinsho shinkeigaku = Clinical neurology [ 1882-0654 ] ; 2010.

RBID : pubmed:21921459

English descriptors

KwdEn :
- Animals, Disease Models, Animal, Disease Progression, Dopaminergic Neurons (pathology), Endpoint Determination, Humans, Indans (administration & dosage), Parkinson Disease (drug therapy), Parkinson Disease (etiology), Parkinson Disease (pathology), Randomized Controlled Trials as Topic.
MESH :
- chemical , administration & dosage : Indans.
- drug therapy : Parkinson Disease.
- etiology : Parkinson Disease.
- pathology : Dopaminergic Neurons, Parkinson Disease.
- Animals, Disease Models, Animal, Disease Progression, Endpoint Determination, Humans, Randomized Controlled Trials as Topic.

PubMed: 21921459

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000A33

Links to Exploration step

pubmed:21921459

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Disease-modifying therapies in PD].</title>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:21921459</idno>
<idno type="pmid">21921459</idno>
<idno type="wicri:Area/PubMed/Corpus">000A33</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A33</idno>
<idno type="wicri:Area/PubMed/Curation">000993</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000993</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Disease-modifying therapies in PD].</title>
<author><name sortKey="Rascol, Olivier" sort="Rascol, Olivier" uniqKey="Rascol O" first="Olivier" last="Rascol">Olivier Rascol</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Rinsho shinkeigaku = Clinical neurology</title>
<idno type="eISSN">1882-0654</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Disease Progression</term>
<term>Dopaminergic Neurons (pathology)</term>
<term>Endpoint Determination</term>
<term>Humans</term>
<term>Indans (administration & dosage)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (etiology)</term>
<term>Parkinson Disease (pathology)</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Indans</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Dopaminergic Neurons</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Disease Models, Animal</term>
<term>Disease Progression</term>
<term>Endpoint Determination</term>
<term>Humans</term>
<term>Randomized Controlled Trials as Topic</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21921459</PMID>
<DateCreated><Year>2011</Year>
<Month>09</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2012</Year>
<Month>09</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>02</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1882-0654</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>50</Volume>
<Issue>11</Issue>
<PubDate><Year>2010</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>Rinsho shinkeigaku = Clinical neurology</Title>
<ISOAbbreviation>Rinsho Shinkeigaku</ISOAbbreviation>
</Journal>
<ArticleTitle>[Disease-modifying therapies in PD].</ArticleTitle>
<Pagination><MedlinePgn>831</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rascol</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Pharmacology and Neurosciences, INSERM U825, and Clinical Investigation Center, University Hospital, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>jpn</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Japan</Country>
<MedlineTA>Rinsho Shinkeigaku</MedlineTA>
<NlmUniqueID>0417466</NlmUniqueID>
<ISSNLinking>0009-918X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007189">Indans</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>003N66TS6T</RegistryNumber>
<NameOfSubstance UI="C031967">rasagiline</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059290" MajorTopicYN="N">Dopaminergic Neurons</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023381" MajorTopicYN="N">Endpoint Determination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007189" MajorTopicYN="N">Indans</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>9</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2012</Year>
<Month>9</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21921459</ArticleId>
<ArticleId IdType="pii">JST.JSTAGE/clinicalneurol/50.831</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000993 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000993 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:21921459
   |texte=   [Disease-modifying therapies in PD].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:21921459" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

[Disease-modifying therapies in PD].

[Disease-modifying therapies in PD].

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki